Some GLP-1 receptor agonists may hold promise as treatments for alcohol use disorder (AUD), a Swedish observational study ...

Semaglutide and liraglutide are associated with reduced AUD and SUD-related hospitalization risks, unlike other GLP-1 ...

Hims & Hers (HIMS) has launched an online GLP-1 supply tracker where people can share information about where the popular ...

So far this year, Eli Lilly (NYSE: LLY) has been on an absolute tear and is swiftly becoming the world's most prolific ...

Among the competitors taking to the course at Pelican Golf Club in Belleair, FL from November 14-17 is Maria Gabriela Lopez, ...

With the rising popularity of telehealth providers offering GLP-1 medications like Ozempic ... [20] Nurse practitioner: A ...

A Lancet study suggests that popular weight loss drugs could lead to muscle loss. Reserachers recommend combining these ...

In September, the company officially relocated its headquarters from a 114,000-square-foot space in New York City to a ...

A small player like Viking may also win by attracting a partner or even a company that will offer to acquire the biotech.

Analyzing H&H's Q3 results and investment strategy in the healthcare industry, highlighting undervaluation and raising the ...

To mark this year’s Pro Bono Week, which concludes today, the CEO’s of the UK’s three main pro bono charities – A4ID, ...